In an interview for the Norwegian TV2, Nina Langeland and Rebecca Cox explained the results of a new study conducted by the University of Bergen and Haukeland University Hospital on long COVID. – As many as 46 percent of the COVID patients in our study report long-term effects, and that is high, said Nina Langeland,…
Read more
We have published a case report about an immunocompromised patient (treated with Rituximab against multiple sclerosis) with longterm fever, hypoxia and low-grade SARS-CoV-2 infection. The patient was hospitalized three times over a period of 102 days. The case report describes the clinical and diagnostic challenges and the interdisciplinary team work needed to distinguish hyperinflammation from…
Read more
Although most people who undergo SARS-CoV-2 infection recover, a significant proportion suffer long-term symptoms and late sequelae, also known as long COVID. We investigated long COVID symptoms in 233 people with a mild to moderate course of acute COVID-19. Our study showed that 46% of COVID-19 infected participants had one or more long COVID symptoms…
Read more
English